理解新时代的兴奋剂使用和使用障碍。
Understanding Stimulant Use and Use Disorders in a New Era.
机构信息
Justine Miner Professor of Addiction Medicine, Department of Family and Community Medicine, University of California, San Francisco, MU3-E, Box 900, 500 Parnassus Avenue, San Francisco, CA 94143-0900, USA.
Professor and Vice Chair for Research, Department of Family Medicine, University of California, Los Angeles, 10880 Wilshire Boulevard, Suite 1800, Los Angeles, CA 90024, USA.
出版信息
Med Clin North Am. 2022 Jan;106(1):81-97. doi: 10.1016/j.mcna.2021.08.010.
Abstract
Extending from the triple wave epidemic of opioid-related overdose deaths, a fourth wave of high mortality involving methamphetamine and cocaine use has been gathering force. This article provides a review of the published literature on stimulants including epidemiology, pharmacology, neurobiology, medical and psychiatric consequences, withdrawal management, and medical and behavioral treatments.
摘要
从阿片类药物相关过量死亡的三重波浪式流行，涉及冰毒和可卡因使用的第四波高死亡率浪潮已经在聚集力量。本文对已发表的关于兴奋剂的文献进行了综述，包括流行病学、药理学、神经生物学、医学和精神病学后果、戒断管理以及医学和行为治疗。
相似文献
1
Understanding Stimulant Use and Use Disorders in a New Era.理解新时代的兴奋剂使用和使用障碍。
Med Clin North Am. 2022 Jan;106(1):81-97. doi: 10.1016/j.mcna.2021.08.010.
2
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.非法芬太尼、兴奋剂的兴起和阿片类药物过量危机的第四波。
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350. doi: 10.1097/YCO.0000000000000717.
3
Methamphetamine Use: A New Wave in the Opioid Crisis?甲基苯丙胺的使用：阿片类药物危机的新一波浪潮？
J Addict Nurs. 2019 Jul/Sep;30(3):219-223. doi: 10.1097/JAN.0000000000000298.
4
Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021.绘制第四波：2010-2021 年美国多药芬太尼过量死亡的地理、时间、种族/族裔和人口趋势。
Addiction. 2023 Dec;118(12):2477-2485. doi: 10.1111/add.16318. Epub 2023 Sep 13.
5
A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.一项关于安非他酮和丁丙诺啡对减少甲基苯丙胺渴望效果的随机临床试验。
Trials. 2019 Jul 30;20(1):468. doi: 10.1186/s13063-019-3554-6.
6
Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.兴奋剂滥用：药理学、可卡因、甲基苯丙胺、治疗、药物治疗尝试
Prim Care. 2011 Mar;38(1):41-58. doi: 10.1016/j.pop.2010.11.004. Epub 2011 Jan 11.
7
Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry.动机和农村地区使用毒品者同时使用兴奋剂和阿片类药物的背景：多地点定性研究。
Harm Reduct J. 2024 Apr 1;21(1):74. doi: 10.1186/s12954-024-00986-z.
8
Persistence and Pervasiveness : Early Wave Opioid Overdose Death Rates Associated With Subsequent Overdose Death Rates.持续性与普遍性：早期阿片类药物过量死亡率与后续过量死亡率的关联
Public Health Rep. 2021 Mar-Apr;136(2):212-218. doi: 10.1177/0033354920969171. Epub 2020 Dec 10.
9
[Current data on methamphetamine].[关于甲基苯丙胺的当前数据]
Rev Prat. 2012 May;62(5):679-81.
10
Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.急性和慢性持续使用甲基苯丙胺会产生不同的长期行为和神经化学后果。
Neurochem Int. 2005 Feb;46(3):189-203. doi: 10.1016/j.neuint.2004.11.004. Epub 2005 Jan 8.
引用本文的文献
1
The mesocorticolimbic system in stimulant use disorder.兴奋剂使用障碍中的中脑皮质边缘系统。
Mol Psychiatry. 2025 Sep 10. doi: 10.1038/s41380-025-03148-0.
2
System dynamics modeling in support of community-based decision-making to reduce opioid overdose fatalities.支持基于社区的决策以减少阿片类药物过量致死的系统动力学建模。
Front Public Health. 2025 Jul 28;13:1616032. doi: 10.3389/fpubh.2025.1616032. eCollection 2025.
3
Individuals recently abstinent from methamphetamine show selective cognitive and behavioral differences when compared to age-matched controls.与年龄匹配的对照组相比，近期戒除甲基苯丙胺的个体表现出选择性的认知和行为差异。
Front Psychiatry. 2025 Jul 11;16:1604252. doi: 10.3389/fpsyt.2025.1604252. eCollection 2025.
4
Adverse childhood experiences and level of self-esteem as predictors for motivation to change among adults with methamphetamine use residing in rehabilitation centers.童年不良经历和自尊水平作为居住在康复中心的甲基苯丙胺使用成瘾成年者改变动机的预测因素。
BMC Psychol. 2025 Jul 1;13(1):712. doi: 10.1186/s40359-025-02997-2.
5
The changing role of substances: trends, characteristics of individuals and prior healthcare utilization among individuals with accidental substance-related toxicity deaths in Ontario Canada.物质角色的变化：加拿大安大略省与物质相关的意外中毒死亡者的趋势、个体特征及既往医疗保健利用情况
PLoS One. 2025 May 23;20(5):e0324732. doi: 10.1371/journal.pone.0324732. eCollection 2025.
6
Effects of a structured SBIRT training program for hospital nursing leaders on utilization of SBIRT within their medical-surgical units: cohort study.针对医院护理领导者的结构化SBIRT培训计划对其在内外科病房中SBIRT应用的影响：队列研究
BMC Nurs. 2025 Apr 23;24(1):450. doi: 10.1186/s12912-025-03079-9.
7
DEMOGRAPHIC PROFILE, SUBSTANCE USE TRENDS AND ASSOCIATED PSYCHOTIC DISORDERS AMONG VETERANS WITH MENTAL HEALTH CONDITIONS: A RETROSPECTIVE COHORT STUDY OF US VETERANS.患有心理健康问题的退伍军人的人口统计学特征、物质使用趋势及相关精神障碍：一项美国退伍军人的回顾性队列研究
ASEAN J Psychiatry. 2024 Jul 12;2024. doi: 10.54615/2231-7805.47358.
8
A multi-method spatial examination of factors associated with changes in geographic accessibility to buprenorphine providers in HEALing communities study states Kentucky, Massachusetts, and Ohio.在“康复社区研究”的肯塔基州、马萨诸塞州和俄亥俄州，对与丁丙诺啡供应商地理可及性变化相关因素进行的多方法空间考察。
Prev Med Rep. 2025 Mar 24;53:103045. doi: 10.1016/j.pmedr.2025.103045. eCollection 2025 May.
9
Controlled Substance Prescribing Patterns Among Fatal Overdose Decedents with an Opioid, Stimulant, or Both Contributing to Death - Pennsylvania, 2017-2022.2017 - 2022年宾夕法尼亚州因阿片类药物、兴奋剂或两者导致死亡的致命过量用药死者的管制药品处方模式
MMWR Morb Mortal Wkly Rep. 2025 Apr 10;74(12):205-209. doi: 10.15585/mmwr.mm7412a2.
10
Primary Care Patient and Clinician Perspectives on Safer Use Strategies for Opioids and/or Stimulants: A Mixed-Method Study.基层医疗患者与临床医生对阿片类药物和/或兴奋剂更安全使用策略的看法：一项混合方法研究。
J Gen Intern Med. 2025 Mar 4. doi: 10.1007/s11606-025-09418-5.
本文引用的文献
1
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.非法芬太尼、兴奋剂的兴起和阿片类药物过量危机的第四波。
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350. doi: 10.1097/YCO.0000000000000717.
2
Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants.阿片类药物在涉及可卡因和苯丙胺类兴奋剂的药物过量死亡中的共同作用。
NCHS Data Brief. 2021 Apr(406):1-8.
3
Adverse childhood experiences and stimulant use disorders among adults in the United States.美国成年人的不良童年经历与兴奋剂使用障碍。
Psychiatry Res. 2021 May;299:113870. doi: 10.1016/j.psychres.2021.113870. Epub 2021 Mar 13.
4
International snapshot of new psychoactive substance use: Case study of eight countries over the 2019/2020 new year period.国际新型精神活性物质使用情况概览：2019/2020 跨年期间八个国家的案例研究。
Water Res. 2021 Apr 1;193:116891. doi: 10.1016/j.watres.2021.116891. Epub 2021 Feb 3.
5
Bupropion and Naltrexone in Methamphetamine Use Disorder.丁丙诺啡与安非他酮治疗甲基苯丙胺使用障碍
N Engl J Med. 2021 Jan 14;384(2):140-153. doi: 10.1056/NEJMoa2020214.
6
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity.美国按性别、种族和族裔划分的甲基苯丙胺过量死亡人数。
JAMA Psychiatry. 2021 May 1;78(5):564-567. doi: 10.1001/jamapsychiatry.2020.4321.
7
Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?治疗可卡因使用障碍的药物治疗策略——我们有什么可以提供的？
Addiction. 2021 Apr;116(4):694-710. doi: 10.1111/add.15242. Epub 2020 Sep 28.
8
A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.共患阿片类药物使用障碍的兴奋剂使用障碍患者药物治疗的系统评价和荟萃分析。
Drug Alcohol Depend. 2020 Nov 1;216:108193. doi: 10.1016/j.drugalcdep.2020.108193. Epub 2020 Aug 1.
9
Substance use disorders: diagnosis and management for hospitalists.物质使用障碍：住院医师的诊断与管理
J Community Hosp Intern Med Perspect. 2020 May 21;10(2):117-126. doi: 10.1080/20009666.2020.1742495.
10
Rise in Presence of Methamphetamine in Oral Fluid Toxicology Tests Among Outpatients in a Large Healthcare Setting in the Northeast.东北地区某大型医疗机构门诊中口腔液毒物学检测中检出甲基苯丙胺的比例上升。
J Addict Med. 2021;15(1):85-87. doi: 10.1097/ADM.0000000000000695.
Zotero 插件